Skip to Content

Ondansetron Hydrochloride Injection

Last Updated: March 9, 2018
Status: Current

Ondansetron Hydrochloride Injection

Products Affected - Description
    • Zofran injection, Novartis, 2 mg/mL, 20 mL vial, 1 count, NDC 00173-0442-00
    • Ondansetron injection, Apotex, 2 mg/mL, 2 mL vial, 25 count, NDC 60505-6130-05
    • Ondansetron injection, AuroMedics, 2 mg/mL, 2 mL vial, 25 count, NDC 55150-0125-02
    • Ondansetron injection, AuroMedics, 2 mg/mL, 20 mL vial, 1 count, NDC 55150-0126-20
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 10 count, NDC 23155-0547-41
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
    • Ondansetron injection, Heritage, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 2 mL vial, 25 count, NDC 67457-0441-20
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 1 count, NDC 67457-0440-20
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL iSecure syringe, 10 count, NDC 00409-1120-12
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
    • Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02
    • Ondansetron injection, West-Ward, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
Reason for the Shortage
    • Apotex did not provide a reason for the shortage.
    • Athenex has ondansetron injection available.
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi has ondansetron injection available.
    • Heritage has ondansetron on shortage due to increased demand.
    • Mylan Institutional did not provide a reason for the shortage.
    • Pfizer has ondansetron injection on shortage due to manufacturing delays.
    • Sagent did not provide a reason for the shortage.
    • West-Ward did not provide a reason for the shortage.
    • Novartis did not provide a reason for the shortage.
Available Products
    • Ondansetron injection, Athenex, 2 mg/mL, 2 mL vial, 25 count, NDC 70860-0776-02
    • Ondansetron injection, Athenex, 2 mg/mL, 20 mL vial, 1 count, NDC 70860-0777-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0103-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20
    • Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01
    • Ondansetron injection, Sagent, 2 mg/mL, 20 mL vial, 1 count, NDC 25021-0782-20
    • Ondansetron injection, West-Ward, 2 mg/mL, 20 mL vial, 1 count, NDC 00143-9890-01
    • Ondansetron injection, West-Ward, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01

Estimated Resupply Dates

    • Apotex has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of mid-March 2018.
    • AuroMedics has ondansetron 2 mg/mL 2 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Heritagen has all ondansetron presentations on allocation.
    • Mylan Institutional has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company estimates a release date of mid-April 2018 for the 2 mL vials and early-April 2018 for the 20 mL vials.
    • Pfizer has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of late-March 2018. The 2 mg/mL 2 mL iSecure syringes are on back order and the company estimates a release date of June 2019.
    • Sagent has ondansetron 2 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
    • West-Ward has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of March 2018.
    • Novartis has Zofran 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date.

Updated

Updated March 9, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide